Ellen Presby has more than three decades of litigation experience as a lead attorney for personal injury, products liability, and pharmaceutical cases. She earned a bachelor's degree at the University of California Davis and her Juris Doctorate at the Southern Methodist University School of Law. Ellen is licensed in Texas, Arizona, and Pennsylvania, but represents clients throughout the country in both state and federal courts.
Specializing in pharmaceutical injury cases, Ellen has diligently litigated against large drug companies who profited off the sales of drugs that injured countless, innocent individuals. She was co-lead counsel in the consolidated Pradaxa litigation in Connecticut. She was appointed to the Plaintiff Steering Committees for the Risperdal Judicial Council Coordinated Proceeding (JCCP) in California, the Granuflo multi-district litigation in Massachusetts, and the federal hormone replacement therapy (HRT) litigation in Arkansas. Additionally, she was co-lead negotiator in FenPhen, securing $1.25 billion for victims.
Outside the courtroom, Ellen serves as Adjunct Professor at Southern Methodist University (SMU) School of Law where she teaches product liability law. She is a board member of the Public Justice Foundation (including Executive Committee), a board member of the National American Board of Trial Advocates (including Dallas Chapter Executive Committee), and has been Co-chair of the Tort Trial & Insurance Practice (TIPS) section of the American Bar Association (ABA).